NEWTOWN, CT. – August 31, 2018 - New Leaf Pharmaceuticals announced the launch of Rhinodol Nasal Spray—a revolutionary product—delivering the finest and purest CBD (Cannabidiol) using a transmucosal technique to ensure the highest bioavailability possible.
Bioavailability refers to the amount of a drug that is absorbed and available for use in the body compared to the amount of drug delivered or administered. Bioavailability varies greatly depending on the route of administration. CBD is a fat soluble (highly lipophilic) substance and has poor bioavailability—almost as low as 5%--when administered orally through the stomach and gut. The most optimal route of CBD administration has proven to be transmucosal or intranasal (applied through the nose) with almost half the drug (48-62%) being absorbed and available for use in the body.
“I had many patients coming to me about using CBD products and what we found on the market and online wasn’t really going to be very effective for anyone. As a doctor, I knew that getting CBD into the bloodstream was of the utmost importance for efficacy. The results we have seen are extremely impressive”—Dr. Rod Deraney, Co-Founder, New Leaf Pharmaceuticals
Rhinodol is a nasal spray with CBD from Hemp—a naturally occurring cannabinoid constituent of cannabis. The therapeutic possibilities of CBD have exploded in the past decade and its benefits continue to be researched by the medical community in a wide range of areas including: anxiety, cancer, pain relief, neuroprotection, anti-inflammatory, anticonvulsant, antispasmodic, and in the relief of nausea/vomiting/motion sickness.
Cannabidiol formulations have been FDA approved for multiple sclerosis pain and epilepsy.
Learn more about Rhinodol at www.newleafpharma.com.
About New Leaf Pharmaceuticals
Established in 2005, New Leaf is an offspring pharmaceutical company dedicated to improving lives by developing and growing a portfolio of differentiated over-the-counter (OTC) products that are effective and work for your health & well-being. New Leaf’s management team is comprised of industry leaders with unparalleled experience in the development, marketing, and commercialization of prescription and non-prescription medicines.